Casey M. Tansey has served as a member of our Board since 2010. Since 2005, he has served as a general partner of U.S. Venture Partners, a venture capital firm. From 2001 until 2004, Mr. Tansey served as the chief executive officer and president of Epicor Medical, Inc. ( Epicor Medical ), a medical device company. Prior to Epicor Medical, Mr. Tansey was chief executive officer and president of HealthPort, Inc., a publicly held medical device company, which is now a Johnson & Johnson company. Prior to that, he was with Baxter Edward s cardiovascular division for nearly ten years, holding various sales and marketing positions. Mr. Tansey currently serves on the board of directors and as a member of the organization and compensation committee and quality, product supply and technology committee of Inspire Medical Systems, Inc. (NYSE: INSP), Shoulder Innovations, Inc. (NYSE: SI), where he serves as a member of the compensation committee and nominating and corporate governance committee, and previously served on the board of directors of Intersect ENT, Inc. from 2006 until 2017. He also serves on the board of directors for a number of U.S. Venture Partners portfolio of private companies, including: Cagent Vascular, LLC, HighLife Medical Inc. , Luminopia, Inc., MicroTransponder, Inc., Neochord, Inc., Neuros Medical, Inc., CardioKinetix, Inc., and ShiraTronics, Inc. Mr. Tansey received a B.S. and M.B.A. from the College of Notre Dame. We believe that Mr. Tansey s extensive experience as a venture capital investor and as a member of the boards of directors of multiple companies in the medical sector qualify him to serve on our Board.